Topical Cantharidin Revisited: A Phase 2 Study Investigating a Commercially-Viable Formulation of Cantharidin (VP-102) for the Treatment of Molluscum Contagiosum

SKIN The Journal of Cutaneous Medicine
doi 10.25251/skin.2.supp.98
Full Text
Abstract

Available in full text

Date
Authors
Publisher

National Society for Cutaneous Medicine


Related search